InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M
YOKNEAM,
Second Quarter 2024 Highlights:
- Quarterly GAAP revenue of
$86.4 million , a decrease of 36.5% compared to the second quarter of 2023. InMode's proprietary surgical technology platforms engaged in minimally invasive and subdermal ablative treatments represented 87% of its quarterly revenues, while 6% were derived fromInMode's traditional laser and non-invasive RF platforms and 7% were derived fromInMode's hands-free platforms. Pro-forma revenue (including pre-orders of new platforms not yet delivered) of$102.6 million . - GAAP net income of
$23.8 million , compared to$55.7 million in the second quarter of 2023; *non-GAAP net income of$29.0 million , compared to$62.2 million in the second quarter of 2023.**Pro-Forma non-GAAP net income of$39.8 million . - GAAP diluted earnings per share of
$0.28 , compared to$0.65 in the second quarter of 2023; *non-GAAP diluted earnings per share of$0.34 , compared to$0.72 in the second quarter of 2023.**Pro-Forma non-GAAP diluted earnings per share of$0.46 . - Quarterly revenues from consumables and service of
$21.0 million , a decrease of 3% compared to the second quarter of 2023. - Total cash position of
$729.2 million as ofJune 30, 2024 , including cash and cash equivalents, marketable securities, and short-term bank deposits.
( |
||
|
Q2 2024 |
Q2 2023 |
Revenues |
|
|
Gross Margins |
80 % |
84 % |
Net Income |
|
|
Earnings per Diluted Share |
|
|
*Non-GAAP Results
( |
||
|
Q2 2024 |
Q2 2023 |
Gross Margins |
81 % |
84 % |
Net Income |
|
|
Earnings per Diluted Share |
|
|
**Pro-Forma Non-GAAP Results
( |
||
|
Q2 2024 |
Q2 2023 |
Revenue |
|
|
Gross Margins |
82 % |
84 % |
Net Income |
|
|
Earnings per Diluted Share |
|
|
|
||
*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A |
||
** Pro-forma non-GAAP results includes pre-orders of new platforms not yet delivered and excludes share-based compensation. |
Management Comments
"The second quarter was challenging for
"In addition, as the leading company in the industry, we continue to invest in research and development, and our innovation pipeline is strong. As we offer unique platforms and technologies that require adjustments to the production lines, I would like to recognize the commitment and dedication of our employees who work tirelessly to expedite the production and fulfill orders during these times," Mizrahy concluded.
Second Quarter 2024 Financial Results
Total GAAP revenues for the second quarter of 2024 reached
"During the second quarter, we began delivering the new platforms and we are on track to complete all deliveries within the next several months," said
GAAP gross margin for the second quarter of 2024 was 80% compared to a gross margin of 84% for the Second quarter of 2023. *Non-GAAP gross margin for the second quarter of 2024 was 81% compared to a gross margin of 84% for the second quarter of 2023.
**Pro-forma non-GAAP gross margin for the second quarter of 2024 was 82%.
GAAP operating margin for the second quarter of 2024 was 21%, compared to an operating margin of 42% in the Second quarter of 2023. *Non-GAAP operating margin for the second quarter of 2024 was 27% compared to 47% for the Second quarter of 2023. **Pro-forma non-GAAP operating margin for the second quarter of 2024 was 34%. This decrease was primarily attributable to the decrease in systems sales in
2024 Financial Outlook
Management provided an outlook for the full year of 2024 ending
- Full Year 2024 revenue to be
$430 to$440 million compared to prior guidance of$485 million to$495 million - *Non-GAAP gross margin between 82% and 84% consistent with prior guidance
- *Non-GAAP income from operations between
$150 million and$155 million compared to prior guidance of$169 million to$174 million - *Non-GAAP earnings per diluted share between
$1.92 and$1.96 compared to previous guidance of$2.01 to$2.05
|
This outlook is not a guarantee of future performance, and stockholders should not rely on such forward-looking statements. See "Forward- |
|
*Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A |
|
** Pro-forma non-GAAP results includes pre-orders of new platforms not yet delivered and excludes share-based compensation. |
|
Based on our 2024 Financial Outlook, it is not expected that there should be any difference between our Pro-forma non-GAAP results and |
The Current Situation in
Regarding the current situation in
Use of Non-GAAP Financial Measures
In addition to
Conference Call Information
Mr. Moshe Mizrahy, Chief Executive Officer, Dr.
The Company encourages participants to pre-register for the conference call using the following link:
https://dpregister.com/sreg/10190152/fcd9be3160.
Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.
For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.
International Dial-in Number: 1-412-317-5736
Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=GpRhmBhV
At:
The conference call will also be webcast live from a link on
Replay Pin Number: 2791553
To access the replay using an international dial-in number, please select the link below:
https://services.choruscall.com/ccforms/replay.html
A replay of the conference call will also be available for 90 days on
About
Forward-Looking Statements
The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or
Company Contact:
Chief Financial Officer Phone: (949) 305-0108 Email: Yair.Malca@inmodemd.com |
Investor Relations Contact:
Email: ir@inmodemd.com
|
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
( (Unaudited) |
|||||
|
|||||
|
Three months ended |
Six months ended |
|||
|
2024 |
2023 |
2024 |
2023 |
|
REVENUES |
86,449 |
136,081 |
166,733 |
242,155 |
|
COST OF REVENUES |
17,116 |
22,054 |
33,481 |
40,308 |
|
GROSS PROFIT |
69,333 |
114,027 |
133,252 |
201,847 |
|
OPERATING EXPENSES: |
|
|
|
|
|
Research and development |
3,698 |
3,567 |
7,216 |
6,669 |
|
Sales and marketing |
45,055 |
51,059 |
84,850 |
92,772 |
|
General and administrative |
2,266 |
2,392 |
4,780 |
4,400 |
|
TOTAL OPERATING EXPENSES |
51,019 |
57,018 |
96,846 |
103,841 |
|
OPERATIONS INCOME |
18,314 |
57,009 |
36,406 |
98,006 |
|
Finance income, net |
8,690 |
4,445 |
16,674 |
7,734 |
|
INCOME BEFORE INCOME TAXES |
27,004 |
61,454 |
53,080 |
105,740 |
|
INCOME TAXES |
3,186 |
5,725 |
5,566 |
9,506 |
|
NET INCOME |
23,818 |
55,729 |
47,514 |
96,234 |
|
|
|
|
|
|
|
EARNINGS PER SHARE: |
|
|
|
|
|
Basic |
0.28 |
0.67 |
0.56 |
1.16 |
|
Diluted |
0.28 |
0.65 |
0.55 |
1.12 |
|
WEIGHTED AVERAGE NUMBER OF SHARES |
|
|
|
|
|
Basic |
83,878 |
83,405 |
84,205 |
83,280 |
|
Diluted |
85,890 |
85,650 |
86,520 |
85,579 |
|
CONDENSED CONSOLIDATED BALANCE SHEETS
( (Unaudited) |
||
|
||
|
J une 30, 2024 |
2023 |
Assets |
|
|
CURRENT ASSETS: |
|
|
Cash and cash equivalents |
91,997 |
144,411 |
Marketable securities |
333,517 |
373,647 |
Short-term bank deposits |
303,694 |
223,547 |
Accounts receivable, net of allowance for credit losses |
38,154 |
42,362 |
Prepaid expense and other receivables |
23,003 |
16,268 |
Inventories |
52,627 |
45,095 |
TOTAL CURRENT ASSETS |
842,992 |
845,330 |
NON-CURRENT ASSETS: |
|
|
Accounts receivable, net of allowance for credit losses |
3,100 |
3,670 |
Deferred income tax asset |
1,402 |
1,506 |
Operating lease right-of-use assets |
9,246 |
9,698 |
Property and equipment, net |
2,396 |
2,382 |
Other investments |
700 |
700 |
TOTAL NON-CURRENT ASSETS |
16,844 |
17,956 |
TOTAL ASSETS |
859,836 |
863,286 |
Liabilities and shareholders' equity |
|
|
CURRENT LIABILITIES: |
|
|
Accounts payable |
15,548 |
13,966 |
Contract liabilities |
43,610 |
10,923 |
Other liabilities |
38,532 |
39,247 |
TOTAL CURRENT LIABILITIES |
97,690 |
64,136 |
NON-CURRENT LIABILITIES: |
|
|
Contract liabilities |
3,455 |
3,766 |
Other liabilities |
1,899 |
1,399 |
Operating lease liabilities |
5,671 |
6,613 |
TOTAL NON-CURRENT LIABILITIES |
11,025 |
11,778 |
TOTAL LIABILITIES |
108,715 |
75,914 |
|
|
|
TOTAL SHAREHOLDERS' EQUITY |
751,121 |
787,372 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
859,836 |
863,286 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
( (Unaudited) |
||||||
|
||||||
|
|
Three months ended |
Six months ended |
|||
|
2024 |
2023 |
2024 |
2023 |
|
|
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
|
|
Net income |
23,818 |
55,729 |
47,514 |
96,234 |
|
|
Adjustments required to reconcile net income to net cash provided by operating activities: |
|
|
|
|
|
|
Depreciation and amortization |
177 |
184 |
342 |
372 |
|
|
Share-based compensation expenses |
5,158 |
6,505 |
9,141 |
10,714 |
|
|
Change in allowance for credit losses of trade receivable |
97 |
261 |
284 |
239 |
|
|
Loss on marketable securities, net |
112 |
- |
141 |
- |
|
|
Finance income, net |
(5,040) |
(1,197) |
(9,797) |
(2,709) |
|
|
Deferred income taxes |
(56) |
43 |
(93) |
62 |
|
|
Changes in operating assets and liabilities: |
|
|
|
|
|
|
Decrease (increase) in accounts receivable |
(4,814) |
(7,949) |
4,494 |
(5,708) |
|
|
Increase in other receivables |
(4,048) |
(3,791) |
(6,717) |
(4,020) |
|
|
Decrease (increase) in inventories |
(1,025) |
2,243 |
(7,532) |
1,329 |
|
|
Increase (decrease) in accounts payable |
2,325 |
1,308 |
1,582 |
(2,947) |
|
|
Increase (decrease) in other liabilities |
2,241 |
7,211 |
(5,562) |
(15,832) |
|
|
Increase (decrease) in contract liabilities (current and non-current) |
23,114 |
(7,547) |
32,376 |
(3,621) |
|
|
Net cash provided by operating activities |
42,059 |
53,000 |
66,173 |
74,113 |
|
|
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
Investment in short-term deposits |
(55,000) |
(25,000) |
(86,297) |
(28,000) |
|
|
Proceeds from short-term deposits |
13,500 |
31,500 |
13,500 |
34,500 |
|
|
Purchase of fixed assets |
(246) |
(194) |
(358) |
(535) |
|
|
Purchase of marketable securities |
(64,129) |
(54,190) |
(185,693) |
(132,119) |
|
|
Proceeds from sale of marketable securities |
33,910 |
- |
47,375 |
- |
|
|
Proceeds from maturity of marketable securities |
89,690 |
60,891 |
181,808 |
111,605 |
|
|
Net cash provided by (used in) investing activities |
17,725 |
13,007 |
(29,665) |
(14,549) |
|
|
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
Repurchase of ordinary shares |
(88,980) |
- |
(88,980) |
- |
|
|
Exercise of options |
395 |
827 |
629 |
2,500 |
|
|
Net cash provided by (used in) financing activities |
(88,585) |
827 |
(88,351) |
2,500 |
|
|
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH |
(132) |
60 |
(571) |
251 |
|
|
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
(28,933) |
66,894 |
(52,414) |
62,315 |
|
|
|
|
|
|
|
|
|
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD |
120,930 |
92,961 |
144,411 |
97,540 |
|
|
CASH AND CASH EQUIVALENTS AT END OF PERIOD |
91,997 |
159,855 |
91,997 |
159,855 |
|
Revision of prior period financial information
The Company revised certain items within the investing activities with no impact on the net cash used in investing activities. The items impacted were "Investment in short-term deposits" and "Proceeds from short-term deposits" which were decreased by
These changes have no impact on our previously reported consolidated total cash flows from operating activities, financing activities and investing activities in the periods stated above as well as net income and net change in cash and cash equivalents.
The Company evaluated the materiality of the adjustments, individually and in the aggregate, considering both qualitative and quantitative factors, and concluded that it was immaterial to the Company's prior periods' consolidated financial information. Since the revision was not material to any prior interim period or annual consolidated financial statements, no amendments to previously filed interim or annual periodic financial information was required. Consequently, the Company has revised the historical consolidated financial information presented herein for the impact of the above.
CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS
( (Unaudited) |
|||||||||||
|
|||||||||||
|
Three months ended |
Six months ended |
|||||||||
2024 |
2023 |
2024 |
2023 |
||||||||
Revenues by Category: |
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||
Capital Equipment revenues - |
34,799 |
41 % |
73,828 |
54 % |
65,658 |
39 % |
123,579 |
51 % |
|||
Capital Equipment revenues - International |
30,606 |
35 % |
40,635 |
30 % |
57,529 |
35 % |
77,008 |
32 % |
|||
Total Capital Equipment revenues |
65,405 |
76 % |
114,463 |
84 % |
123,187 |
74 % |
200,587 |
83 % |
|||
Consumables and service revenues |
21,044 |
24 % |
21,618 |
16 % |
43,546 |
26 % |
41,568 |
17 % |
|||
Total Revenue |
86,449 |
100 % |
136,081 |
100 % |
166,733 |
100 % |
242,155 |
100 % |
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
Six months ended |
||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||
|
% |
% |
% |
% |
||||||||
|
|
International |
Total |
|
International |
Total |
|
International |
Total |
|
International |
Total |
Revenues by Technology: |
|
|
|
|
|
|
|
|
|
|
|
|
Minimal-Invasive |
85 |
86 |
87 |
86 |
73 |
81 |
87 |
84 |
86 |
88 |
74 |
83 |
Hands-Free |
11 |
4 |
7 |
11 |
6 |
9 |
9 |
3 |
6 |
10 |
6 |
8 |
Non-Invasive |
4 |
10 |
6 |
3 |
21 |
10 |
4 |
13 |
8 |
2 |
20 |
9 |
|
100 |
100 |
100 |
100 |
100 |
100 |
100 |
100 |
100 |
100 |
100 |
100 |
RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME
( (Unaudited) |
|
||||||
|
|
|
|||||
Three months ended |
Three months ended |
|
|||||
GAAP |
Share Based |
Non-GAAP |
GAAP |
Share Based |
Non-GAAP |
|
|
REVENUES |
86,449 |
- |
86,449 |
136,081 |
- |
136,081 |
|
COST OF REVENUES |
17,116 |
(471) |
16,645 |
22,054 |
(547) |
21,507 |
|
GROSS PROFIT |
69,333 |
471 |
69,804 |
114,027 |
547 |
114,574 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
Research and development |
3,698 |
(559) |
3,139 |
3,567 |
(757) |
2,810 |
|
Sales and marketing |
45,055 |
(3,824) |
41,231 |
51,059 |
(4,731) |
46,328 |
|
General and administrative |
2,266 |
(304) |
1,962 |
2,392 |
(470) |
1,922 |
|
TOTAL OPERATING |
51,019 |
(4,687) |
46,332 |
57,018 |
(5,958) |
51,060 |
|
OPERATIONS INCOME |
18,314 |
5,158 |
23,472 |
57,009 |
6,505 |
63,514 |
|
Finance income (expense), net |
8,690 |
- |
8,690 |
4,445 |
- |
4,445 |
|
INCOME BEFORE INCOME TAXES |
27,004 |
5,158 |
32,162 |
61,454 |
6,505 |
67,959 |
|
INCOME TAXES |
3,186 |
- |
3,186 |
5,725 |
- |
5,725 |
|
NET INCOME |
23,818 |
5,158 |
28,976 |
55,729 |
6,505 |
62,234 |
|
|
|
|
|
|
|
|
|
EARNINGS PER SHARE: |
|
|
|
|
|
|
|
Basic |
0.28 |
|
0.35 |
0.67 |
|
0.75 |
|
Diluted |
0.28 |
|
0.34 |
0.65 |
|
0.72 |
|
WEIGHTED AVERAGE NUMBER OF |
|
|
|
|
|
|
|
Basic |
83,878 |
|
83,878 |
83,405 |
|
83,405 |
|
Diluted |
85,890 |
|
85,900 |
85,650 |
|
86,243 |
|
|
Six months ended |
Six months ended |
||||
GAAP |
Share Based |
Non-GAAP |
GAAP |
Share Based |
Non-GAAP |
|
REVENUES |
166,733 |
- |
166,733 |
242,155 |
- |
242,155 |
COST OF REVENUES |
33,481 |
(880) |
32,601 |
40,308 |
(901) |
39,407 |
GROSS PROFIT |
133,252 |
880 |
134,132 |
201,847 |
901 |
202,748 |
OPERATING EXPENSES: |
|
|
|
|
|
|
Research and development |
7,216 |
(987) |
6,229 |
6,669 |
(1,258) |
5,411 |
Sales and marketing |
84,850 |
(6,707) |
78,143 |
92,772 |
(7,769) |
85,003 |
General and administrative |
4,780 |
(567) |
4,213 |
4,400 |
(786) |
3,614 |
TOTAL OPERATING EXPENSES |
96,846 |
(8,261) |
88,585 |
103,841 |
(9,813) |
94,028 |
OPERATIONS INCOME |
36,406 |
9,141 |
45,547 |
98,006 |
10,714 |
108,720 |
Finance income (expense),net |
16,674 |
- |
16,674 |
7,734 |
- |
7,734 |
INCOME BEFORE INCOME TAXES |
53,080 |
9,141 |
62,221 |
105,740 |
10,714 |
116,454 |
INCOME TAXES |
5,566 |
- |
5,566 |
9,506 |
- |
9,506 |
NET INCOME |
47,514 |
9,141 |
56,655 |
96,234 |
10,714 |
106,948 |
|
|
|
|
|
|
|
EARNINGS PER SHARE: |
|
|
|
|
|
|
Basic |
0.56 |
|
0.67 |
1.16 |
|
1.28 |
Diluted |
0.55 |
|
0.65 |
1.12 |
|
1.24 |
WEIGHTED AVERAGE NUMBER OF |
|
|
|
|
|
|
Basic |
84,205 |
|
84,205 |
83,280 |
|
83,280 |
Diluted |
86,520 |
|
86,531 |
85,579 |
|
86,062 |
Logo: https://mma.prnewswire.com/media/1064477/4839231/InMode_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-reports-second-quarter-2024-financial-results-quarterly-revenue-of-86-4m-represents-36-5-year-over-year-decrease-pro-forma-revenue-including-new-platform-pre-orders-not-yet-delivered-of-102-6m-302211666.html
SOURCE